CAPRISA

Results: 65



#Item
1Press Release: MayOmololu Falobi Award for Excellence in HIV Prevention Research Community Advocacy Presented to a Pioneering Community Educator Who Brings the Voices of Community Members and Participants t

Press Release: MayOmololu Falobi Award for Excellence in HIV Prevention Research Community Advocacy Presented to a Pioneering Community Educator Who Brings the Voices of Community Members and Participants t

Add to Reading List

Source URL: www.global-campaign.org

Language: English - Date: 2010-06-03 11:42:00
2FACTS 001 QA 2.9.14_MB MS LC KA.docx.docx

FACTS 001 QA 2.9.14_MB MS LC KA.docx.docx

Add to Reading List

Source URL: www.usaid.gov

Language: English - Date: 2015-02-24 14:32:35
3Using Antiretrovirals to Prevent HIV: Implications of the outcome of the CAPRISA 004 tenofovir-gel microbicide trial SAVE THE DATE: Tuesday, 20 July 2010, 6.30pm-8.30pm An official satellite of XVII International AIDS Co

Using Antiretrovirals to Prevent HIV: Implications of the outcome of the CAPRISA 004 tenofovir-gel microbicide trial SAVE THE DATE: Tuesday, 20 July 2010, 6.30pm-8.30pm An official satellite of XVII International AIDS Co

Add to Reading List

Source URL: www.global-campaign.org

Language: English - Date: 2010-06-23 14:57:49
    4Results of the CAPRISA 004 trial of tenofovir gel Salim S Abdool Karim Pro Vice-Chancellor (Research): University of KwaZulu-Natal Director: CAPRISA

    Results of the CAPRISA 004 trial of tenofovir gel Salim S Abdool Karim Pro Vice-Chancellor (Research): University of KwaZulu-Natal Director: CAPRISA

    Add to Reading List

    Source URL: www.global-campaign.org

    Language: English - Date: 2010-07-21 08:27:48
      5What is CAPRISA 004? CAPRISA 004 was a phase IIb, two-arm, double-blind, randomised, placebo-controlled trial designed to assess the safety and effectiveness of the vaginal microbicide candidate 1% tenofovir gel for the

      What is CAPRISA 004? CAPRISA 004 was a phase IIb, two-arm, double-blind, randomised, placebo-controlled trial designed to assess the safety and effectiveness of the vaginal microbicide candidate 1% tenofovir gel for the

      Add to Reading List

      Source URL: www.global-campaign.org

      Language: English - Date: 2010-07-06 15:54:36
        6GC News #113: August 3, 2009 GC News is a forum for exchange on new HIV prevention options, especially for women. Global Meet GCM’s Africa Programme Team Research Updates

        GC News #113: August 3, 2009 GC News is a forum for exchange on new HIV prevention options, especially for women. Global Meet GCM’s Africa Programme Team Research Updates

        Add to Reading List

        Source URL: www.global-campaign.org

        Language: English - Date: 2009-08-19 11:43:10
        7Medicine / Health / Microbicides for sexually transmitted diseases / HIV / Clinical trial / Antiretroviral drug / Sexually transmitted disease / CAPRISA 004 / Vaginal microbicide / Microbicides / Microbiology / Sexually transmitted diseases and infections

        Microbicides Research & Development

        Add to Reading List

        Source URL: www.global-campaign.org

        Language: English - Date: 2010-06-24 18:55:00
        8MAKING IT COUNT BRIEFING SHEET 8  MICROBICIDES This Making it Count briefing sheet provides an overview on the current status of research towards the development of microbicides for sexual health promoters working with g

        MAKING IT COUNT BRIEFING SHEET 8 MICROBICIDES This Making it Count briefing sheet provides an overview on the current status of research towards the development of microbicides for sexual health promoters working with g

        Add to Reading List

        Source URL: makingitcount.org.uk

        Language: English - Date: 2011-05-31 14:13:59
        9

        PDF Document

        Add to Reading List

        Source URL: www.unicri.it

        Language: English - Date: 2009-03-11 11:25:52
        10

        PDF Document

        Add to Reading List

        Source URL: www.unaids.org

        Language: English - Date: 2015-04-13 11:53:00